Low incidence of acute GVHD and relapse in standard risk patients undergoing allogeneic transplantation with CSA and MTX prophylaxis

被引：0
|
作者：
Byrne, JL [1 ]
Stainer, C [1 ]
Miflin, G [1 ]
Haynes, AP [1 ]
Russell, NH [1 ]
机构：
[1] City Hosp Nottingham, Nottingham, England
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
409
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [21] Impact of GvHD-prophylaxis regimen on incidence and severity of gastrointestinal toxicities and acute GvHD after allogeneic HSCT
    Niestadtkoetter, J.
    Mueller, L.
    Mueller-Tidow, C.
    Weber, T.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S181 - S181
  • [22] Unrelated donor stem cell transplantation in children:: Low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole, iv-immunoglobutin and ATG
    Finckenstein, FG
    Zabelina, T
    Dürken, M
    Dahlke, J
    Kröger, N
    Krüger, W
    Janka-Schaub, G
    Erttmann, R
    Zander, AR
    Kabisch, H
    KLINISCHE PADIATRIE, 2002, 214 (04): : 206 - 211
  • [23] CsA plus MTX plus MMF plus low-dose ATG protocal for GVHD prophylaxis in unrelated donor hematopoietic stem cell transplantation.
    Liu, QF
    Sun, J
    Zhang, Y
    Liu, XL
    Xu, D
    BLOOD, 2003, 102 (11) : 473B - 473B
  • [24] Acute/chronic GVHD after allogeneic transplantation in paediatric patients
    Llinares, E
    Fernández, JM
    Verdeguer, A
    Cañete, A
    Aliaga, J
    Castel, V
    BONE MARROW TRANSPLANTATION, 2002, 30 : S62 - S62
  • [25] Impact of acute GVHD on survival and disease relapse in paediatric patients undergoing allogeneic stem cell transplantation for acute lymphoblastic leukaemia: an EBMT registry-based analysis
    Lucchini, G.
    Bertaina, A.
    Galimard, J. E.
    Kalwak, K.
    Dalle, J. -H.
    Locatelli, F.
    Taskinen, M.
    Mirci-Danicar, O.
    Sedlacek, P.
    Balduzzi, A.
    Ghemlas, I.
    Styczynski, J.
    Kitra-Roussou, V.
    Tbakhi, A.
    Fagioli, F.
    Bertrand, Y.
    Aljurf, M.
    Ifversen, M.
    Dalissier, A.
    Bader, P.
    Corbacioglu, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 87 - 88
  • [26] Role of acute GVHD in paediatric patients undergoing allogeneic stem cell transplantation for acute myeloid leukaemia: an imperfect balance
    Lucchini, G.
    Bertaina, A.
    Galimard, J. E.
    Benakli, M.
    Kalwak, K.
    Dalle, J. H.
    Danicar, O. Mirci
    Ayas, M.
    Locatelli, F.
    Skorobogatova, E.
    Bertrand, Y.
    Styczynski, J.
    Tbakhi, A.
    Sedlacek, P.
    Balduzzi, A.
    Ifversen, M.
    Versluijs, B.
    Jubert, C.
    Dalissier, A.
    Bader, P.
    Corbacioglu, S.
    BONE MARROW TRANSPLANTATION, 2022, 57 (SUPPL 1) : 88 - 88
  • [27] ABO incompatibility and relapse risk in patients undergoing allogeneic marrow transplantation for acute myeloid leukemia -: Response to Mielcarek et al
    Mehta, J
    BONE MARROW TRANSPLANTATION, 2002, 30 (08) : 548 - 548
  • [28] Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
    Francesca Bonifazi
    Irene Defrancesco
    Jacopo Olivieri
    Francesco Barbato
    Paolo Lopedote
    Michele Dicataldo
    Mariarosaria Sessa
    Elisa Dan
    Barbara Sinigaglia
    Luca Zazzeroni
    Simonetta Rizzi
    Cristina Tassi
    Beatrice Casadei
    Pier Luigi Zinzani
    Mario Arpinati
    Bone Marrow Transplantation, 2021, 56 : 2295 - 2298
  • [29] Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas
    Bonifazi, Francesca
    Defrancesco, Irene
    Olivieri, Jacopo
    Barbato, Francesco
    Lopedote, Paolo
    Dicataldo, Michele
    Sessa, Mariarosaria
    Dan, Elisa
    Sinigaglia, Barbara
    Zazzeroni, Luca
    Rizzi, Simonetta
    Tassi, Cristina
    Casadei, Beatrice
    Zinzani, Pier Luigi
    Arpinati, Mario
    BONE MARROW TRANSPLANTATION, 2021, 56 (09) : 2295 - 2298
  • [30] Sirolimus and mycophenolate mofetil as GVHD prophylaxis in allogeneic stem cell transplantation for high-risk leukaemia patients
    Schleuning, M.
    Judith, D.
    Stuebig, T.
    Jedlickova, Z.
    Funk, F.
    Heshmat, M.
    Baurmann, H.
    Schwerdtfeger, R.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S109 - S109
12345